title: Hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy.
abstract: We hereby report a case of hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy (CSC). Issues regarding safety and adverse effects of bevacizumab are discussed. To the best of our knowledge, this is the first reported case of hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal CSC.
authors.affiliation: National Institute of Ophthalmology, Pune, India.
authors.forename: Aditya
authors.initials: A
authors.lastname: Kelkar
authors.affiliation: National Institute of Ophthalmology, Pune, India.
authors.forename: Poonam
authors.initials: P
authors.lastname: Gandhi
authors.affiliation: Queens Medical Centre, Nottingham, UK.
authors.forename: Winfried
authors.initials: W
authors.lastname: Amoaku
authors.affiliation: National Institute of Ophthalmology, Pune, India.
authors.forename: Jai
authors.initials: J
authors.lastname: Kelkar
authors.affiliation: National Institute of Ophthalmology, Pune, India.
authors.forename: Shreekant
authors.initials: S
authors.lastname: Kelkar
authors.affiliation: National Institute of Ophthalmology, Pune, India.
authors.forename: Priyanka
authors.initials: P
authors.lastname: Raut
authors.affiliation: National Institute of Ophthalmology, Pune, India.
authors.forename: Rachana
authors.initials: R
authors.lastname: Shah
keywords: Central serous chorioretinopathy; Hemorrhagic macular infarction; Intravitreal bevacizumab